鼻閉塞(Nasal Obstruction):世界の治験レビュー(2015年上半期版)

GlobalDataが発行した調査報告書(GDHC2729CTIDB)
◆英語タイトル:Nasal Obstruction Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2729CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年6月16日
◆ページ数:64
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における鼻閉塞(Nasal Obstruction) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 鼻閉塞(Nasal Obstruction)
  - 当レポートの概要
・鼻閉塞(Nasal Obstruction):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Nasal Obstruction Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Nasal Obstruction Global Clinical Trials Review, H1, 2015″ provides an overview of Nasal Obstruction clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nasal Obstruction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Nasal Obstruction 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Nasal Obstruction Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Merck & Co., Inc. 30
Clinical Trial Overview of Merck & Co., Inc. 30
Zurita Laboratorio Farmaceutico Ltda 31
Clinical Trial Overview of Zurita Laboratorio Farmaceutico Ltda 31
Optinose US Inc. 32
Clinical Trial Overview of Optinose US Inc. 32
Farmoquimica S/A 33
Clinical Trial Overview of Farmoquimica S/A 33
Clinical Trial Overview of Top Institutes / Government 34
Eastern Virginia Medical School 34
Clinical Trial Overview of Eastern Virginia Medical School 34
HaEmek Medical Center 35
Clinical Trial Overview of HaEmek Medical Center 35
Hospital de Clinicas de Porto Alegre 36
Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 36
Kerman Medical University 37
Clinical Trial Overview of Kerman Medical University 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
Mayo Clinic 39
Clinical Trial Overview of Mayo Clinic 39
NHS Grampian 40
Clinical Trial Overview of NHS Grampian 40
Northern Health and Social Care Trust 41
Clinical Trial Overview of Northern Health and Social Care Trust 41
Norwegian University of Science and Technology 42
Clinical Trial Overview of Norwegian University of Science and Technology 42
Radboud University Nijmegen Medical Centre 43
Clinical Trial Overview of Radboud University Nijmegen Medical Centre 43
Five Key Clinical Profiles 44
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables
Nasal Obstruction Therapeutics, Global, Clinical Trials by Region, 2015* 7
Nasal Obstruction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nasal Obstruction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Nasal Obstruction Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Nasal Obstruction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Nasal Obstruction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Nasal Obstruction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Nasal Obstruction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Nasal Obstruction Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Nasal Obstruction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Nasal Obstruction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Nasal Obstruction Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Nasal Obstruction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Nasal Obstruction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Nasal Obstruction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Nasal Obstruction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Nasal Obstruction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 30
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Zurita Laboratorio Farmaceutico Ltda, 2015* 31
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Optinose US Inc., 2015* 32
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Farmoquimica S/A, 2015* 33
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2015* 34
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2015* 35
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015* 36
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kerman Medical University, 2015* 37
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 39
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Grampian, 2015* 40
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Health and Social Care Trust, 2015* 41
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015* 42
Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2015* 43

List of Figures
Nasal Obstruction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Nasal Obstruction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nasal Obstruction Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Nasal Obstruction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Nasal Obstruction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Nasal Obstruction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Nasal Obstruction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Nasal Obstruction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Nasal Obstruction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Nasal Obstruction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Nasal Obstruction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Nasal Obstruction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Nasal Obstruction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Nasal Obstruction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 63

【掲載企業】

Merck & Co., Inc.
Zurita Laboratorio Farmaceutico Ltda
Optinose US Inc.
Farmoquimica S/A

【レポートのキーワード】

鼻閉塞(Nasal Obstruction)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 鼻閉塞(Nasal Obstruction):世界の治験レビュー(2015年上半期版)(Nasal Obstruction Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆